389 related articles for article (PubMed ID: 9357147)
1. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
Raj NS; Guleria R; Misra A; Pande JN
Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
Iwasaki E; Baba M
Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
5. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
Boner AL; Sette L; Vallone G; Plebani M; Messori A
Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
[TBL] [Abstract][Full Text] [Related]
6. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
7. Theophylline clearance in undernourished asthma patients.
Raj NS; Misra A; Guleria R; Pande JN
Indian J Chest Dis Allied Sci; 1998; 40(3):175-8. PubMed ID: 9919837
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic equivalence of a generic slow-release theophylline tablet.
Hendeles L; Breton AL; Beaty R; Harman E
Pharmacotherapy; 1995; 15(1):26-35. PubMed ID: 7739942
[TBL] [Abstract][Full Text] [Related]
9. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
Jones DT; Sears MR
N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
[TBL] [Abstract][Full Text] [Related]
10. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
Brown DL; Maddux MS; Organek HW; Bauman JL
Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
[TBL] [Abstract][Full Text] [Related]
11. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
Okuma M; Iikura Y
Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
[TBL] [Abstract][Full Text] [Related]
13. Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet.
Lagas M; Jonkman JH
Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):424-6. PubMed ID: 4044074
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
Wang P; Qi M; Zhong D; Fang L
Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
[TBL] [Abstract][Full Text] [Related]
16. Apparent decrease in population clearance of theophylline: implications for dosage.
Asmus MJ; Weinberger MM; Milavetz G; Marshik P; Teresi ME; Hendeles L
Clin Pharmacol Ther; 1997 Nov; 62(5):483-9. PubMed ID: 9390104
[TBL] [Abstract][Full Text] [Related]
17. [Slow-release theophylline for the treatment of asthmatic children].
Iwasaki E; Baba M
Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
[TBL] [Abstract][Full Text] [Related]
18. [Serum concentrations of the pyridoxal and pyridoxal-5'-phosphate in children during sustained-release theophylline therapy].
Tanaka I; Ito Y; Hiraga Y; Fujino M; Kobayashi K
Arerugi; 1996 Oct; 45(10):1098-105. PubMed ID: 8958656
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of sustained-release in theophylline (Slobid, Theolong, Theodur) by pharmacokinetics].
Kotake T; Mihara M; Shibakawa M; Asamoto
Arerugi; 1997 Apr; 46(4):370-5. PubMed ID: 9154697
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
Liebke C; Niggemann B; Wahn U
Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
